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Assessment of hydrogen peroxide in breath condensate as an inflammatory 
marker in asthmatic children. 
 
INTRODUCTION 
Asthma is a leading cause of chronic illness in 
childhood. As many as 10-15% of boys and 7-10% of 
girls may have asthma at sometime during childhood. 
Current data support the hypothesis that inflammation 
underlies the pathophysiology of asthma 1. Activation 
of inflammatory cells induces respiratory burst 
resulting in the production of reactive oxygen species, 
such as hydrogen peroxide 2. 
Oxidative stress, defined as an increased exposure to 
oxidants and/or decreased antioxidant capacities, is 
implicated in inflammatory airway disease. 
Inflammatory cells, especially eosinophils which 
produce more superoxide anions (O2) than neutrophils 
or macrophages, release several reactive oxygen 
radicals. Oxygen radicals are rapidly metabolized to 
form hydrogen peroxide (H2O2), which diffuses into 
the airway lining fluid and may evaporate into exhaled 
air 3. 
Hydrogen peroxide in exhaled breath condensate is 
increased in chronic obstructive airway disease, adult 
respiratory distress syndrome, cigarette smoking, and 
asthma, and may be used as a non invasive marker of 
oxidative stress. However, the effect of corticosteroids 
on production of reactive oxygen species or H2O2 is 
not certain 4. 
This study is aimed to assess hydrogen peroxide 
concentration in exhaled breath condensate as an 
inflammatory marker in bronchial asthma. 
Hydrogen peroxide assessment may be used to monitor 
the inflammatory process in asthmatic patients and is 
to be correlated with the severity of airway obstruction. 
 
METHODS 
This study comprised 85 Egyptian children attending 
the Children's Hospital of Ain Shams University. They 
were 46 males and 39 females. They were classified 
into two groups: 
Group I: It included 50 asthmatic children, 30 males 
and 20 females. Their ages ranged from 3-14 years. 
They were enrolled from the Chest Clinic, Children's 
Hospital, Ain Shams University, during the period 
from January to December 2002. 
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Criteria for diagnosis of asthma: 
The diagnosis of asthma in those patients was based 
upon the criteria of the American Thoracic Society 
(ATS) 5 which defined diagnosis of asthma according 
to previous recurrent documented history of wheezing, 
shortness of breath and nocturnal cough. All the 
patients had airway obstruction by pulmonary function 
tests, that reversed by >15% either spontaneously or 
after administration of β2 agonist inhalation. 
Classification of asthmatic children: 
According to National Heart, Lung and Blood 
Institutes (NHLBI)6 asthmatic children were 
subclassified into: 
1. Moderate asthmatic children: included 20 
children, 14 males and 6 females their ages 
ranged from 3–14 years (mean ±SD: 9±3 years). 
2. Severe asthmatic children: included 30 children, 
17 males and 13 females their ages ranged from 
3-14 years (mean ±SD: 9±3 years). 
Group (II): Controls (In H2O2 measurement) This 
group included 35 healthy children, age and sex 
matched, thoroughly examined, 16 males and 19 
females their ages ranged from 4-15 years (mean ±SD: 
9±4 years). 
Methods: Asthmatic children in the study were 
subjected to the following 
1. Full medical history: including 
- Frequency of attacks. 
- Nocturnal symptoms. 
- Seasonal variation. 
- Medications received, dose and 
frequency [100% used salbutamol, 
12% budesonide, 80% fluticasone, 
34% montelukast and 12% were also 
receiving other medications e.g.: 
cough sedatives, oral theophylline]. 
- Allergic background (food allergy was 
verified from the history). 
- Other atopic disease (e.g. nasal, 
dermal). 
* Environmental conditions: (to define bad housing) 
- Socioeconomic standard. 
- Animal and bird contact. 
- Housing: old/ new, ventilation, sun 
exposure, humidity and exposure to 
fumes and dust 
2. Complete clinical examination: 
3. Laboratory investigations: 
a- Complete blood count (CBC) with 
calculation of absolute eosinophilic 
(AEC) and absolute neutrophilic counts 
(Coulter counter, MicroDiff 17, USA). 
b- Pulmonary function tests (PFTs): 
Spirometric pulmonary function tests 
were done, using a pocket spirometer, 
which can operate as a stand-alone 
pocket spirometer, or connected with a 
personal computer (MIR Spirobank, 
Ocean Co., Italy, Roma). 
Parameters measured 
- FVC: forced vital capacity  
- FEV1: volume expired in the 1st 
second of test     
- FEV1 %: (FEV1 / FVC x 100). 
- FEF25-75: average flow 25 - 75% 
of FVC. 
Spirometry: starting testing: 
Inserting the disposable mouth piece at the set and 
fitted well and fit the nose clip to the nose in order to 
ensure that no air can escape from the nostrils, then 
hold the spiroband facing the user then switch on the 
set to the testing pattern. Put the free end of mouth 
piece well into the mouth for at least 2 cm inside the 
mouth and close the side of mouth tightly around the 
mouth piece. 
Start to breath into the machine according to the test 
(better in a standing position). 
FVC test: 
First, start the test by breathing at rest for a few 
moments, then when ready to start, inspire slowly, as 
much as possible (and this is made easier by holding 
the arms wide apart). Then, make a complete 
expiration as fast as possible, complete the cycle by 
inspiring again as quickly as possible. 
The test may be repeated several times by repeating the 
cycle without taking the mouth piece out of the patient. 
c- Hydrogen peroxide measurement: (Done for 
patients and controls) by using Dekhuijzen et al.7 
technique (calorimetric assay). 
Reagents used: 
1) 420 µ M tetra-methyl Benzidine dissolved in 
0.42 M citrate buffer at pH 3.8. 
2) Horseradish peroxides (HRP) (Sigma 
chemicals, Pole, UK). 
3) 18 µ M sulphuric acid. 
Instruments: 
- Valve-mouth piece. 
- Sterile plastic tube. 
- Spectrophotometer. 
Technique: 
A patient was asked to breathe into a valve-mouth 
piece for 15` and air was directed into a vial kept at 
10°C. The vial was cooled in ice and 1 ml condensate 
breath was collected and stored at 70° in a 2-mL sterile 
plastic. A 100 mL of 420 µ M, tetramethyl benzidine 
with 10 mL of enzyme stock solon was reacted for 20` 
at room temperature. The mixture was acidified to pH1 
by 10 mL of 18 H2O4. The reaction production was 
measured spectro-photometrically at 450 nm 7. 
Statistical Analysis: 
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Data collected is coded, tabulated and introduced to a 
PC for statistical analysis. Quantitative data are 
presented as mean ± standard deviation, while 
qualitative data are described as frequency table i.e., 
number and percentage. Two group comparison, for 
quantitative data was performed using student t-test, 
while chi-squared test was used to test association 
between 2 variables in case of qualitative data.  
Correction was done if the sample is less than 30 and 
Fisher Exact was performed if less than 2 expected 
observations were encountered. P value was set at 
0.05. All statistical manipulations were performed 




The results of the present study showed that asthmatic 
children had significant elevation of the mean H2O2 
concentration in expired air (0.345±0.16 µM/L) 
compared to normal controls (0.137±0.04 µM/L) with 
p value <0.001 (Figure 1). 
Study of asthma triggers, showed  a significant 
increase in asthmatic attacks frequency and degree of 
severity with bad housing (Tables 1 and 2). However, 
all asthma triggers showed non significant correlation 
to the mean value of H2O2 concentration in expired air 
of asthmatic children.  
There was no significant statistical variation in 
H2O2 concentration in expired air of asthmatic children 
with the grade of asthma severity (mean value in 
severe patients 0.321±0.16 µM/L, and in moderate 
patients 0.379 ± 0.16 µM/L). 
 
Table (1): Average frequency of the attacks/month 
in relation to different precipitating factors. 




Bad housing   
   - Present         28% 8.71±5.2 <0.01 
Sig    - Absent         72% 4.0±2.5 
Passive smoke   




   - Present         82% 4.87±3.8 NS    - Absent         12% 7.33 
Food allergy   
   - Present         38% 4.89±3.5 NS    - Absent         62% 5.58±4.3 
Family history   
   - Present         8% 3.75±2.9 NS    - Absent         92% 5.45±4.1 
Animal contact   
   - Present         8% 7.50±4.1 NS 




   - Present         4%    8.0 NS    - Absent         96% 5.2 
Similarly, the values of spirometric PFTs (FVC, 
FEV1, FEV1% and PEF) expressed as a percentage of 
predicted for age and sex (Table 3), did not 
significantly correlate to H2O2 concentration in expired 
air of asthmatic children (with r values respectively 
0.173, 0.243, 0.050 and 0.183). 
Mean value of H2O2 concentration in expired air of 
asthmatic children receiving inhaled steroid therapy 
(44 patients) was 0.343±0.1 µM/L, which was 
comparable to the mean value of asthmatic children not 
on inhaled steroids (0.355±0.1 µM/L). 
Correlations of H2O2 concentration in expired air 
of asthmatic children with total leukocytic counts (r 
value 0.043), eosinophilic counts (r value 0.077) and 
neutrophilic counts (r value -0.038) were all non 
significant. 
 
Table (2): Relation of grades of bronchial asthma to 
the presence and absence of different precipitating 
factors. 
Grade 
 Moderate No (%) 
Severe 
No (%) p value 
Bad housing    
   - Present 2(14.3) 12(85.7 0.04  
S    - Absent 18(50.0) 18(50.0) 
Passive smoke    
   - Present 15(37.5) 25(62.5) NS    - Absent 5(50.0) 5(50.0) 
Upper respiratory 
tract infection    
   - Present 16(39.0) 25(61.0) NS    - Absent 4(44.4) 5(55.6) 
Food allergy    
   - Present 8(42.1) 11(57.9) NS    - Absent 12(38.7) 19(61.3) 
Family history    
   - Present 2(50.0) 2(50.0) NS    - Absent 18(39.1) 28(60.9) 
Animal contact    
   - Present 1(25.0) 3(75.0) NS    - Absent 19(41.3) 27(58.7) 
Atopy    
   - Present    - 2(100.0) NS    - Absent 20(41.7) 28(58.3) 
S= Significant, NS= non-significant. 
 
Table (3): Pulmonary function tests (PFTs) 
parameters of bronchial asthma patients. 
 Mean SD Range 
FEV1 80.9 21.8 33 - 166 
FVC 81.7 20.7 35 - 154 
H2O2 in breath of asthmatic children 
 
 65 
FEV1% 93.1 13.5 35 - 110 
PEF 74.3 19.4 25 - 110 
The values of PFTs are expressed as a percentage 












p value < 0.001 
Fig. (1): Mean value of H2O2 level in expired air 




Asthma is a major chronic airway disorder that is a 
serious public health problem in countries through out 
the world. Asthma affects people of all ages, can be 
severe, and is sometimes fatal. Over 100 million 
people worldwide have asthma, and the prevalence is 
increasing especially among children 8.  
In the present study 28% of the patients had bad 
housing environment (like poor ventilation, high 
humidity, overcrowding, poor exposure to the sun, low 
socio-economic status and bad housing hygiene). 
Samet et al. 9 reported that levels of respirable 
particulates, nicotine, polyaromatic hydrocarbons, CO, 
NO and many other pollutant substances increase with 
the indoor smoke, the intensity of smoking, and air 
exchange rate inside houses. This usually occurs in 
families of low socio-economic status and in 
overcrowded homes.  
Studies done by Andriessen et al. 10 revealed that 
there is a significant relation between dampness and 
moulds in the house and the presence of asthmatic 
symptoms and cough in children. In the present study 
there was a significant positive correlation between 
bad housing environment and the number of asthmatic 
attacks/month. Similarly, there was a significant 
positive correlation between bad housing and the 
degree of severity of asthma. This stresses the 
importance of bad housing environment in relation to 
asthma pathogenesis. 
Bronchial asthma is characterized by reversible 
lower airway obstruction and pulmonary function tests 
(PFTs) are considered a useful way to objectively 
measure the degree, location and reversibility of lung 
compromise in asthmatic children 11. 
Spirometric parameters in this study showed 
average mean values of forced vital capacity (FVC) 
and forced expiratory volume in 1st second (FEV1) 
compared to predicted values for age and sex of 
examined patients (either value was more than 80% of 
predicted). Nevertheless, the mean value of peak 
expiratory flow (PEF) was slightly lowered than the 
average value predicted for age and sex, it was 74% 
and normal average value more than 80% 12. This 
signified an obstructive lung disease; however this was 
mild, and could be explained by the fact that our 
patients were regularly on asthma controller and 
reliever medications.  
The mean value of FEV1/FVC ratio (FEV1%) was 
higher than 90% in our asthmatic children. This could 
be explained by the fact that younger children often 
have an FEV1/FVC ratio of more than 90%, and even 
FEV1 was nearly equal to FVC. This might be 
explained by physiological and anatomical features of 
developing chest in children which expire almost all 
the FVC in 1st second. Accordingly, the occurrence of 
airway obstruction in the pediatric age groups, may not 
be accompanied by a significant decrease in FEV1% 11. 
The present study showed that there was no 
significant relation between the different medications 
used and the pulmonary function test parameters. It 
was observed that 100% of asthmatic children needed 
to use asthma relievers (e.g. salbutamol) on different 
occasions and 92% needed to use inhaled steroids as a 
controller medication (80% used fluticazone and 12% 
used budesonide) regularly. 
The dose of fluticazone ranged from 50µg-
500µg/day.  Budesonide dose ranged from 200 µg - 
400 µg/day. 34% of our patients were on regular oral 
intake of a leukotriene modifier (montelukast) as an 
asthma controller. Other drugs (oral theophylline, 
cough sedative, and expectorant) were used regularly 
in 12% of patients. 
A study done by Barnes 13 reported that the regular 
treatment with inhaled steroids diminished asthma 
symptoms, decreased asthma exacerbations and 
decreased the need for bronchodilator. Russell and 
Ninan 14 reported that inhaled steroids are effective in 
children of all ages and even in younger children, it 
can improve symptoms score. Unfortunately, 
corticosteroids do not appear to cure asthma. Its 
withdrawal is accompanied by rapid return of airway 
hyper-responsiveness and symptoms 15. 
Airway inflammation is important in the 
development and progression of asthma 16.  Oxidative 
stress contributes to airway inflammation; activation of 
inflammatory cells such as eosinophils and neutrophils 
induces a respiratory burst resulting in production of 
superoxide anion (Ò2). This oxidant species undergoes 
spontaneous or enzyme catalized dismutation to form 
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hydrogen peroxide (H2O2). Hydrogen peroxide is one 
of the most stable of the reactive oxygen metabolites. 
Due to lack of charge, it may easily penetrate cellular 
membranes and may generate hydroxyl radicals in 
presence of iron cations (Fenton reaction). H2O2 and 
hydroxyl radicals are able to react with membrane and 
lipid components of bronchial lining fluid and cause 
their peroxidation. Similarly, they diffuse into the 
airway lining fluid and may evaporate into exhaled 
air17. We hypothesized that expired breath H2O2 
concentration may serve as a simple, non invasive 
method to document airway inflammation.  
In the present study, the hydrogen peroxide (H2O2) 
in expired breath condensate was significantly higher 
in asthmatic cases compared to the controls. This 
agrees with previous studies 1,2,18-21. They reported that 
the level of exhaled H2O2 was elevated significantly in 
asthmatic patients compared with normal control 
subjects. There was no other single reported study of 
H2O2 in asthmatic children to show normal values of 
H2O2 in expired air. This could be explained by the fact 
that asthmatic patients have an enhanced number and 
activity of inflammatory cells specially neutrophils. 
This induces a respiratory burst resulting in generation 
of cytotoxic oxygen metabolites such as superoxide 
radicals and hydrogen peroxide. Sufficient quantities 
of hydrogen peroxide may be utilized by 
myeloperoxidase to mediate cytotoxicity via 
hypochlorous acid 22. H2O2 appears to be an important 
reactive oxygen species causing cellular injury, 
perhaps via further reactions leading to more reactive 
species such as hydroxyl radicals and lipid 
peroxidation products 23. 
In the present study, we found no significant 
relation between the levels of H2O2 in expired air of 
asthmatic patients and the degree of severity of asthma. 
This could be explained by the fact that moderate 
asthmatics as well as severe asthmatics still have 
significant on-going inflammatory process in airways. 
Sznajder et al. 24 reported that the level of H2O2 in 
expired air was elevated in patients with mild asthma. 
However, a study done by Horvath et al. 20 revealed 
that the level of H2O2 in expired air was also elevated 
in severe unstable asthmatic patients. This was 
explained by the fact that the patients with severe 
asthma who are still symptomatic presumably have 
ongoing high degree of inflammation. 
Our present study showed no significant 
correlation between levels of H2O2 in expired air of 
asthmatic patients and the spirometry test parameters 
for age and sex. This was in accordance with 
Emelyanov et al. 2 who reported that expired H2O2 
levels were elevated in asthmatic patients with FEV1 
>80% of predicted values. However, there was a 
significant correlation between the elevated  H2O2 level 
and inhalation provocation test using histamine. This 
could be explained by the fact that increased oxidative 
stress in asthmatic patients is directly correlated with 
airway hyperresponsiveness  as manifested by 
bronchial challenge test. This denotes that even with 
mild asthmatic symptoms and normal spirometric 
values there is an ongoing airway inflammation with 
increased oxidative stress.   
In contrast, Loukides et al.1 found that in asthmatic 
patients there was significant correlation between H2O2 
concentration in expired breath condensate and lung 
function impairment. In that study there was a positive 
correlation between H2O2 in expired air and peak 
expiratory flow rate (PEFR) variability; also H2O2 
inversely correlated with FEV1% predicted. Another 
study done by Sont 25 reported that there was a 
significant negative correlation between exhaled H2O2, 
and FEV1% predicted in asthmatic patients. 
We did not observe a significant correlation 
between the level of H2O2 in expired air in asthmatic 
patients and the eosinophilic and neutrophilic counts in 
peripheral blood. Vachier et al.26 found a significant 
correlation between eosinophil and neutrophil counts 
in induced sputum and  the H2O2 concentrations in 
expired breath condensate of asthmatic patients. 
Another study done by Ronchi et al27 reported that 
there was a significant correlation between exhaled 
H2O2 in asthmatic patients and the eosinophil counts in 
induced sputum. Emelyanov et al.2 found that there 
was elevated number of total leukocytes especially 
mast cells, activated eosinophils and T-cells in 
bronchial biopsy specimen from an asthmatic patient 
and it was significantly correlated with the elevated 
level of expired H2O2. Sputum and lung biopsy cell 
counts are thus considered more accurate in the 
assessment of the local inflammation cell burden. 
Further studies for H2O2 in asthmatic children are 
recommended and are to be correlated to sputum 
absolute counts of eosinophils and neutrophils.  
Finally, we can conclude that the hydrogen 
peroxide in exhaled breath condensate is an easy 
marker to assess the ongoing inflammatory process in 
asthmatic patients. Although the patients were on 
controller medications and the pulmonary function 
tests parameters were within the average mean values 
for age and sex, the H2O2 level in expired air of these 
asthmatic patients showed highly significant elevation 
compared to the level in normal control subjects. This 
suggests that the oxidative stress might not be well 
controlled by the medications; so we may consider a 
new policy for the management of asthma including 
using higher inhaled steroid doses,  antioxidant therapy 
and/or anti-inflammatory drugs other than steroids. 
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